ECSP license


Verified platform

Accumeo gives investors of all kinds the opportunity to invest in companies they believe in and share in their success.

Minimum investment
2,500 SEK
Advertised return
Payment options
Total funding volume
What does Accumeo offer?

Accumeo was founded to help individuals invest in one of the historically fastest growing types of assets: unlisted stocks. Since the beginning of the 2000s, over-the-counter shares have returned almost 3 times more than listed shares.

Accumeo makes promising unlisted investment opportunities available to more people, while giving innovative growth companies access to the capital they need.

Accumeo enables all types of investors to be part owners at the stage of greatest growth, while supporting the growth of companies at the time they need support most.

We believe that crowdfunding works best as a direct, seamless connection between entrepreneurs and committed investors from all backgrounds. That’s why investors on our platform get voting rights, along with the chance to benefit from future dividends, IPOs and sales of the companies they invested in.

Profile strength: Intermediate
Would you invest via Accumeo?
What is the target industry of the Accumeo crowdfunding website?

Accumeo offers to invest in various crowdfunding opportunities from the Startups, SME sector.

What is the minimum amount needed to invest at Accumeo crowdfunding platform?

At Accumeo, you can start investing with 2500€.

What types of investment does the Accumeo crowdfunding platform provide?

The investment models Accumeo operates is Equity.

Accumeo alternatives

Report an issue
Let us know if you have any concerns about the data presented for this platform.
Thanks for letting us know
Have a nice day :)
crowdfunding report 2023
Get our latest European Crowdfunding Market Report 2023

Our brand new report gives insights into the state of the crowdfunding market in general and goes in-depth regarding funding volumes, backer and fundraiser profiles, regulatory implications, technical challenges and more. Grab your copy, it's FREE!